Anand R, Penta S, Cui Z, Fairbairn N, Socías ME Redesigning a stopped clinical trial as an emulated trial using real-world data to explore the effectiveness of slow-release oral morphine as a treatment for opioid use disorder Subst Use Addctn J PubMed

Bozinoff N, Lei J, Mihic T, Moe J, Palis H, Nolan S, Ti L, Kennedy MC Uptake of low-dose buprenorphine initiation and associated patient characteristics in British Columbia, Canada: a population-based cohort study J Addict Med PubMed

Lu C, Chan K, Martin L, Fairbairn N "We need all hands on deck": characterizing addiction medicine training in Canada - a mixed methods study of fellowship program directors Addict Sci Clin Pract PubMed

Young S, Raboud J, Dodd Z, DeBeck K, Milloy MJ, Wilson D, Hayashi K, Bayoumi AM, Fairbairn N Examining the association between fentanyl use and perceived adequacy of methadone dose: a retrospective cohort study Drug Alcohol Depend PubMed

Young S, Fairbairn N, Cui Z, Bach P, Mok WY, Budau J, Slaunwhite A, Ti L, Hayashi K, Nolan S Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: a retrospective cohort study from British Columbia, Canada Addiction PubMed

Crepeault H, Ti L, Bach P, Wood E, Jutras-Aswad D, Le Foll B, Lim R, Socías ME Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: findings from a pragmatic, pan-Canadian, randomized control trial Am J Addict PubMed

Gallant K, Nijjar P, DeBeck K, Cui M, Kerr T Barriers and facilitators to accessing opioid agonist therapy for street-involved adolescents and young adults in Vancouver J Addict Med PubMed

Robinson S, Brohman I, van Draanen J, Kushner R, Fairbairn N, Glegg S Innovations to the ECHO model to enhance reach and network-building among addiction clinicians in Western Canada Addict Sci Clin Pract PubMed

Nosyk B, Min JE, Homayra F, Kurz M, Guerra-Alejos BC, Yan R, Piske M, Seaman SR, Bach P, Greenland S, Karim ME, Siebert U, Bruneau J, Gustafson P, Kampman K, Korthuis PT, Loughin T, McCandless LC, Platt RW, Schnepel KT, Socías ME Buprenorphine/naloxone vs methadone for the treatment of opioid use disorder JAMA PubMed

Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Socías ME Comparative effectiveness of buprenorphine/naloxone and methadone on methamphetamine/amphetamine use among people with opioid use disorder in Canada Subst Use Addctn J PubMed